Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04985383 · ClinicalTrials.gov registry record · NA
Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis
A NA study, sponsored by Alkahest.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04985383 is a NA study that has completed, run by Alkahest. The registered enrollment target is 10 participants.
The verdict
NCT04985383, a NA study, has completed, sponsored by Alkahest.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is to evaluate the safety and tolerability of the AKST1210 column at blood-flow rates greater than 250 mL/min in subjects with end-stage renal disease (ESRD) undergoing hemodialysis (HD). The study will assess the safety, tolerability, and impact on HD parameters when the AKST1210 column is used at a blood-flow of up to 450 mL/min.
Interventions
- DEVICE AKST1210 S-15 at 250 mL/min
- DEVICE AKST1210 S-15 at 450 mL/min
- DEVICE AKST1210 S-25 at 250 mL/min
- DEVICE AKST1210 S-25 at 450 mL/min
- DEVICE AKST1210 S-35 at 250 mL/min
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-03-11 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04985383
The ClinicalTrials.gov registry entry for NCT04985383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alkahest, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which AKST1210 S-15 at 250 mL/min is the first listed.
NCT04985383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04985383 about?
NCT04985383 is a clinical study titled "Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis". This study is to evaluate the safety and tolerability of the AKST1210 column at blood-flow rates greater than 250 mL/min in subjects with end-stage renal disease (ESRD) undergoing hemodialysis (HD). The study will assess the safety, tolerability, and impact on HD parameters when the AKST1210 column ...
What is the current status of trial NCT04985383?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-03-11. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT04985383?
The interventions under investigation include: AKST1210 S-15 at 250 mL/min (DEVICE), AKST1210 S-15 at 450 mL/min (DEVICE), AKST1210 S-25 at 250 mL/min (DEVICE), AKST1210 S-25 at 450 mL/min (DEVICE), AKST1210 S-35 at 250 mL/min (DEVICE).
Who is sponsoring clinical trial NCT04985383?
This trial is sponsored by Alkahest, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.